SHC1 and cancer: The frequency of MCT-1 and Shc gene co-activation was again studied, and the results showed that 58.1% of the cancer patients exhibited high activation of both MCT-1 and Shc genes but only 11.3% of cases expressed low-level of both genes (Table 3).